Abstract

Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death globally with an immense cost burden; however, it takes years to develop, which offers prevention opportunities (AHRQ, 2022). A gap in preventative practice is statin underutilization (Akhabue et al., 2017). The ASCVD risk estimator tool was published to assess patients' 10-year risk and offer recommendations for statin therapy (Lloyd-Jones et al., 2019).

The project aimed to evaluate whether implementation of the ASCVD risk estimator into primary care practice resulted in a difference in statin prescription rates and patterns, and to assess barriers to patient statin acceptance.

Author Details

Brittany Burris, DNP, APRN, FNP-C

Sigma Membership

Omega Iota

Type

Dissertation

Format Type

Text-based Document

Study Design/Type

Quasi-Experimental Study, Other

Research Approach

Quantitative Research

Keywords:

Prevention, Cardiovascular Disease, Statins, ASCVD

Advisor

Kathy Lenz

Degree

DNP

Degree Grantor

Graceland University

Degree Year

2023

Rights Holder

All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.

All permission requests should be directed accordingly and not to the Sigma Repository.

All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.

Review Type

None: Degree-based Submission

Acquisition

Self-submission

Date of Issue

2023-12-14

Full Text of Presentation

wf_yes

Download

Available for download on Sunday, May 31, 2026

Share

COinS